Each of these myeloid cell populations are known to inhibit the ability of T lymphocytes to expand and exert their cytotoxic functions, suggesting a potential mechanism behind the impaired T cell anti-tumor responses observed in tumor bearing Stat4−/− mice. This evidence concerns the gene STAT4 and neoplasm.